Lucio Lara Santos. Completed the Title of Aggregate in Medical Sciences in 2019 by the Abel Salazar Institute of Biomedical Sciences of the University of Porto, PhD in Medicine in 2003 by the Faculty of Medicine of the University of Porto, Master in Oncobiology in 1993 by the Faculty of Medicine of the University of Porto and Doctor in Medicine in 1985 from the Faculty of Medicine of Agostinho Neto University (Angola). At the Portuguese Institute of Oncology of Porto Francisco Gentil EPE, he is a member of the Scientific Council of the IPOFG-CRP, a member of the Antibiotics Committee of the Department of Oncological Surgery, a member of the group responsible for the Oncological Registry, Coordinator of the Hepato-bilio-pancreatic Surgery Unit from the Digestive Pathology Clinic, Research Coordinator of the Experimental Pathology and Therapeutics group and Director of the Intermediate Care Unit. Currently, he is an Associate Professor at the Abel Salazar Institute of Biomedical Sciences of the University of Porto, Associate Professor at the Fernando Pessoa University, and he also develops teaching activities at 4 more universities in the country. He adds activities as a collaborator at the Institute for Research and Innovation in Health, as well as at the Research and Studies Center of the Fernando Pessoa University. Develops/developed scientific review activities in 11 specialty journals and is part of the editorial board of 2 national/international journals. He is an integral member of 9 national/international societies in the field of surgery and oncology and is President of the General Assembly at the Association For Drug Discovery And Development. Participates and/or participated as a researcher in 30 projects and responsible researcher in 2 pre-clinical and clinical research projects registered in national and international entities. Additionally, he participates and/or participated as a principal investigator in 6 research projects funded by pharmaceutical, hospital (IPO Porto) and higher education institutions and as a co-investigator in 5. He was coordinator of 3 research projects funded by the Ministry of Health and co-investigator on 2. It is worth noting that he is the principal investigator of the phase I clinical trial "Luzz 11", the first phase I oncology clinical trial carried out in Portugal. At the present time he has more than 156 publications in specialist journals, having written 13 book chapters and 7 books in the field of Oncology and Dentistry. He has participated in the evaluation jury of degrees, masters and doctorates as president of the jury, examiner or member at the University of Porto, University of Coimbra, Universidade Nova de Lisboa, University of Minho, University of Aveiro, University of Trás-os-Montes, Beira Interior and Fernando Pessoa University. Additionally, he organized several scientific events in the country and in Lusophone African Countries, being the founding member of the GICD Academy. Participates actively and annually in several national and international conferences on oncology and surgery, fostering the growing discussion around Precision Medicine. He works in the areas of Medical and Health Sciences and Natural Sciences, having supervised 10 doctoral theses, 11 master's theses and 17 monographs / dissertations in these areas to obtain an academic degree. He co-supervised 5 doctoral theses and 2 master theses. At the present time, he supervises 15 PhD / Master's students in the capacity of supervisor or co-supervisor. In his research career he was distinguished with an award and/or honor on 5 occasions. He adds to this curriculum several missions in Guinea-Bissau, Angola, Cape Verde and Mozambique, in coordination with national and international entities, with the aim of improving cancer care in those countries.